home
about us
our story
OUR MISSION
OUR VALUES
OUR PARTNERS
OUR SCIENTIFIC CO-FOUNDERS
OUR MANAGEMENT
OUR BOARD
TALENTS
exl01
EXL01
CROHN’S DISEASE
F. prau
partnerships
Programs
MANUFACTURING PILOT UNIT
REGULATORY EXPERTISE
INTELLECTUAL PROPERTY
newsroom
PUBLICATIONS
contact
menu
about us
about us
Our story
Our mission
Our values
Our partners
Our Scientific Co-founders
Our management
Our board
Talents
exl01
EXL01
Exl01
Crohn's Disease
F. prau
pipeline
pipeline
Programs
Manufacturing Pilot Unit
Regulatory Expertise
Intellectual Property
newsroom
newsroom
Corporate Presentation
Publications
News
Upcoming Events
contact
I-lab2018 Bpifrance
Jul 23, 2018
Exeliom Biosciences is awarded I-Lab2018 from Bpifrance
Back to news
Manufacturing
May 7, 2021
Exeliom Biosciences opens pilot manufacturing unit for Live Biotherapeutics (LBPs) thanks to European H2020 Accelerator Program
Explore
Wilco
Sep 27, 2017
Exeliom Biosciences joins Wilco Incubator
Explore
Clinical Trial Live Biotherapeutics Crohn's Disease Belgium
Feb 24, 2022
Exeliom Biosciences announces approval of Clinical Trial Application from the Belgian Agency for Single Strain Live Biotherapeutic EXL01 (Faecalibacterium prausnitzii) for the treatment of Crohn’s Disease
Explore
contact
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.